SEATTLE, WA, March 26, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, today announced that Segra International has engaged CFN Media to conduct a 6-month pre-public and public markets investor visibility program to begin on March 22, 2018.
“Segra International is a biotechnology company that specializes in cannabis micropropagation, commonly known as tissue culture,” said Frank Lane, President of CFN Media. “This process replaces traditional cloning from mother plants with rapid, sterile production of robust and healthy plantlets. It generates exact copies of the original plant without the risk of pathogens and other issues that can plague cultivators. The company is poised to go public on the Canadian Securities Exchange (CSE) in the fall of 2018.
Segra recently announced an agreement with Hydropothecary Corporation (TSXV:THCX) to incorporate Segra’s micropropagation technology into their production process which will allow Hydropothecary to significant scale up rapidly to serve the growing medical and recreational cannabis markets.
“Segra is executing its plan to build micropropagation nurseries in both Canada and California capable of producing millions of disease free plant starts for licensed producers,” said Todd McMurray, CEO of Segra.
CFN Media will leverage its powerful content platform and extensive reach into mainstream and cannabis-focused investor audiences and media across North America to attract high-quality investors to Segra International while elevating the company’s financial brand.
Learn how to become a CFN Media client company, brand or entrepreneur: http://www.cannabisfn.com/become-featured-company/
Download the CFN Media iOS mobile app to access the world of cannabis from the palm of your hand: https://itunes.apple.com/us/app/cannabisfn/id988009247?ls=1&mt=8
Or visit our homepage and enter your mobile number under the Apple App Store logo to receive a download link text on your iPhone: http://www.cannabisfn.com
About CFN Media
CFN Media (CannabisFN), the leading agency and financial media network dedicated to the worldwide cannabis industry, helps companies operating in the space attract investors, capital, and publicity. Private and public marijuana companies in the US and Canada rely on CFN Media to succeed in the capital markets.
About Segra International
Segra is a plant biotechnology company that specializes in industrial-scale cannabis plant micropropagation. The company is developing industrial-scale cannabis micropropagation laboratories to produce healthy, robust plantlets for licensed cannabis producers globally. Segra has assembled a world-class team of specialists in the areas of plant tissue culture, agronomy, molecular genetics, regulatory compliance, and corporate finance. The Segra team includes Dr. Sma Zobayed, Segra’s Director of Micropropagation. Dr. Zobayed is a world-renowned micropropagation specialist who has successfully micropropagated over 500 species of plants including cannabis. Dr. Zobayed has successfully developed a protocol for true-to-type cannabis micropropagation (including 4–7 x multiplication of plant stock over a 30-day period). Segra will help its clients improve product quality, rapidly expand operations, decrease liabilities associated with pest and disease, and increase profits.
Forward Looking Statements
Certain statements in this presentation are "forward-looking statements". Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance (often, but not always using words or phrases such as "expect", "seek", "endeavor", "anticipate", "plan", "estimate", "believe", "intend", or stating that certain actions, events or results may, could, would, might or will occur or be taken, or achieved) are not statements of historical fact and may be "forward-looking statements". Forward-looking statements are based on expectations, estimates and projections at the time the statements are made and involve significant known and unknown risks, uncertainties and assumptions which would cause actual results or events to differ materially from those presently anticipated. A number of factors could cause actual results, performance or achievements to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements, including, but not limited to: (i) general business risk and liability; (ii) reliance on licenses; (iii) reliance on facilities; (iv) limited operating history; (v) unfavorable publicity or consumer perception; (viii) management of growth; (viii) reliance on management; (ix) conflicts of interest;; (x) limited market for securities; (xi) liquidity risk; (xiii) regulatory risks; (xiv) environmental and employee health and safety regulations; (xv) changes in laws, regulations and guidelines; (xvi) restrictions on sales and marketing; (xvii) competition; (xviii) risks inherent in an agricultural business; (xix) vulnerability to rising energy costs; (xx) product liability; and (x) operating risks and insurance coverage. Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking statements prove incorrect, actual results, performance or achievements could vary materially from those expressed or implied by the forward-looking statements contained in this document. Investors should not place undue reliance on these forward-looking statements. Although the forward-looking statements contained in this document are based upon what management of Segra currently believe to be reasonable assumptions, Segra cannot assure prospective investors that actual results, performance or achievements will be consistent with these forward-looking statements. Except as required by law, Segra does not have any obligation to advise any person if it becomes aware of any inaccuracy in or omission from any forward-looking statement, nor does it intend, or assume any obligation, to update or revise these forward-looking statements to reflect new events or circumstances. The foregoing statements expressly qualify any forward-looking information contained herein.